Antineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantAntineoplastic AgentsCisplatinMotion SicknessDoxorubicinCombined Modality TherapyCyclophosphamideTreatment OutcomeBreast NeoplasmsLung NeoplasmsNeoplasmsNauseaPaclitaxelNeoplasm StagingDisease-Free SurvivalDrug Resistance, NeoplasmPrognosisCarboplatinSurvival AnalysisDrug Administration ScheduleVomitingSurvival RateTaxoidsNeoadjuvant TherapyNeoplasm Recurrence, LocalMedical OncologyCarcinoma, Non-Small-Cell LungEtoposideColorectal NeoplasmsOvarian NeoplasmsNeoplasm MetastasisTime FactorsMethotrexateQuality of LifeFatigueCell Line, TumorInduction ChemotherapyVinblastineProspective StudiesIfosfamideDisease ProgressionBleomycinDeoxycytidineOrganoplatinum CompoundsAntimetabolites, AntineoplasticApoptosisFluorouracilAnthracyclinesAntineoplastic Agents, AlkylatingChemotherapy, Cancer, Regional PerfusionCytarabineSalvage TherapyFollow-Up StudiesTesticular NeoplasmsTransplantation, AutologousNeutropeniaAdenocarcinomaLymphoma, Non-HodgkinAntineoplastic Agents, PhytogenicRadiotherapy, AdjuvantHodgkin DiseaseRadiotherapyPhotic StimulationAntibiotics, AntineoplasticDacarbazineDose-Response Relationship, DrugClinical Trials as TopicNeoplasms, Germ Cell and EmbryonalCarmustineGranulocyte Colony-Stimulating FactorLomustineCamptothecinKaplan-Meier EstimateBrain NeoplasmsPlatinum CompoundsQuestionnairesBone NeoplasmsRetrospective StudiesInfusions, Intra-ArterialOsteosarcomaLeukopeniaMelphalanAntiemeticsMitomycinThiotepaLiver NeoplasmsTumor Markers, BiologicalInfusions, IntravenousHematopoietic Stem Cell TransplantationDrug TherapyPeritoneal NeoplasmsMitoxantroneRecurrenceLymphatic MetastasisStomach NeoplasmsTegafurPalliative CareAntibodies, Monoclonal, HumanizedGerminoma